← Back to headlines

State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee | Blood Cancer Journal

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.

State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee | Blood Cancer Journal · NabkaNews